Loading interactive chart...
1DInterval:
Date Range
1 min
Advertisement
U.S. markets closed
S&P Futures
5,074.50 +12.25 (+0.24%) Dow Futures
38,050.00 +60.00 (+0.16%) Nasdaq Futures
17,720.00 +61.50 (+0.35%) Russell 2000 Futures
1,967.60 +5.60 (+0.29%) Crude Oil
82.84 +0.15 (+0.18%) Gold
2,387.80 -0.60 (-0.03%)
MorphoSys AG (0NDV.IL)
IOB - IOB Delayed Price. Currency in EUR
Follow
At close: 06:10PM BST
Mountain
Settings
- Zacks
Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
Novartis (NVS) enters into a license deal with Arvinas, Inc. (ARVN) for the worldwide development and commercialization of cancer candidate ARV-766. Shares of ARVN rise on the news.
- Zacks
Novartis (NVS) to Undertake Job Cuts in Development Department
Novartis (NVS) is set to cut jobs by 680 in its development organization to reshape workforce.
- ACCESSWIRE
MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
Novartis offers € 68.00 per share in cash, representing a total equity value of € 2.7 billion Shareholders benefit from attractive premium of 94% and 142% on the volume-weighted average price during the last month and three months before January 25, ...
Advertisement
Advertisement
Advertisement